XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2007 by Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by:
Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials
ClinicalTrials.gov Identifier:
NCT00557713
First received: November 13, 2007
Last updated: NA
Last verified: November 2007
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2013
  Estimated Primary Completion Date: No date given